October 23, 2018
Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca
Webcast and conference call for analysts at 2 pm CEST today:
Innate Pharma will host a live webcast and conference call with a Q&A session for analysts and investors at 2pm CEST today to discuss this announcement.
Access to the live webcast: https://edge.media-server.com/m6/p/dic9yxpo
Location |
Purpose |
Phone Number |
---|---|---|
France |
Participant |
+33 (0)1 76 77 22 57 |
United Kingdom |
Participant |
+44 (0)330 336 9411 |
United States |
Participant |
+1 929-477-0324 |
Standard international access |
Participant |
0800 279 7204 |
The participation code is: 6524843
An audio replay file will be made available after the session via Innate Pharma’s website.
Attachment | Size |
---|---|
Webcast presentation | 537.36 KB |
Press Release | 157.24 KB |
Transaction Fact Sheet | 230.77 KB |